FDA Approved: SYMPAZAN — Supplemental Application (Aquestive Therapeutics)

View source ↗

Summary

FDA approved a supplemental application for Sympazan (clobazam) from Aquestive Therapeutics, resulting in changes to the drug’s labeling/indication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Lennox-gastaut Syndrome

Drugs mentioned

• SYMPAZAN (clobazam)

Snippet

SUPPL AP for SYMPAZAN (CLOBAZAM)